These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 12431355)
1. An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines. Dos Santos BA; Ranieri TS; Bercini M; Schermann MT; Famer S; Mohrdieck R; Maraskin T; Wagner MB Rev Panam Salud Publica; 2002 Oct; 12(4):240-6. PubMed ID: 12431355 [TBL] [Abstract][Full Text] [Related]
2. Vaccines for measles, mumps, rubella, and varicella in children. Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766 [TBL] [Abstract][Full Text] [Related]
3. Vaccines for measles, mumps and rubella in children. Demicheli V; Rivetti A; Debalini MG; Di Pietrantonj C Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD004407. PubMed ID: 22336803 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996. dos Santos BA; Stralioto SM; Siqueira MM; Ranieri TS; Bercini M; Schermann MT; Wagner MB; Silveira TR Rev Panam Salud Publica; 2006 Nov; 20(5):299-306. PubMed ID: 17316487 [TBL] [Abstract][Full Text] [Related]
5. Booster immune response in children 6-7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection. Díaz-Ortega JL; Bennett JV; Castañeda-Desales D; Quintanilla DM; Martínez D; de Castro JF Vaccine; 2014 Jun; 32(29):3680-6. PubMed ID: 24837512 [TBL] [Abstract][Full Text] [Related]
6. The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. da Silveira CM; Kmetzsch CI; Mohrdieck R; Sperb AF; Prevots DR Int J Epidemiol; 2002 Oct; 31(5):978-82. PubMed ID: 12435771 [TBL] [Abstract][Full Text] [Related]
7. Vaccines for measles, mumps and rubella in children. Demicheli V; Jefferson T; Rivetti A; Price D Cochrane Database Syst Rev; 2005 Oct; (4):CD004407. PubMed ID: 16235361 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial. Sood A; Mitra M; Joshi HA; Nayak US; Siddaiah P; Babu TR; Mahapatro S; Sanmukhani J; Gupta G; Mittal R; Glueck R Hum Vaccin Immunother; 2017 Jul; 13(7):1523-1530. PubMed ID: 28362563 [TBL] [Abstract][Full Text] [Related]
9. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection. Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672 [TBL] [Abstract][Full Text] [Related]
10. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Marin M; Broder KR; Temte JL; Snider DE; Seward JF; MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530 [TBL] [Abstract][Full Text] [Related]
11. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. Miller E; Andrews N; Stowe J; Grant A; Waight P; Taylor B Am J Epidemiol; 2007 Mar; 165(6):704-9. PubMed ID: 17204517 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials. Leung JH; Hirai HW; Tsoi KK Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133 [TBL] [Abstract][Full Text] [Related]
13. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella. Wellington K; Goa KL Drugs; 2003; 63(19):2107-26. PubMed ID: 12962524 [TBL] [Abstract][Full Text] [Related]
14. No demonstrable association between the Leningrad-Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt. Sharma HJ; Oun SA; Bakr SS; Kapre SV; Jadhav SS; Dhere RM; Bhardwaj S Clin Microbiol Infect; 2010 Apr; 16(4):347-52. PubMed ID: 20222892 [TBL] [Abstract][Full Text] [Related]
15. Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. da Cunha SS; Rodrigues LC; Barreto ML; Dourado I Vaccine; 2002 Jan; 20(7-8):1106-12. PubMed ID: 11803071 [TBL] [Abstract][Full Text] [Related]
16. Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany. Schlipköter U; Mühlberger N; von Kries R; Weil J Infection; 2002 Dec; 30(6):351-5. PubMed ID: 12478324 [TBL] [Abstract][Full Text] [Related]
17. Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design. Ki M; Park T; Yi SG; Oh JK; Choi B Am J Epidemiol; 2003 Jan; 157(2):158-65. PubMed ID: 12522023 [TBL] [Abstract][Full Text] [Related]